Category: Beckman Coulter Inc.
Chinese medical device maker Mindray Medical pays $15 million to settle a "commercial dispute" with Beckman Coulter.
Australia's Genetic Technologies settles a lawsuit against Hologic Inc. alleging patent infringement of its genetic testing technology; also, Nomir Medical settles nasty spat with former patent law firm.
Genetic Technologies (NSDQ:GENE) settled a lawsuit against Hologic Inc. (NSDQ:HOLX) over one of its gene testing patents, leaving seven other defendants in the suit.
Women's health firm Hologic was one of nine original defendants in the lawsuit. The settlement involves the licensing of the patent to Hologic in return for undisclosed financial terms, according to a regulatory filing.
A Florida woman is the latest in what's sure to be a long line of plaintiffs filing personal injury lawsuits against Medtronic Inc. over its controversial Infuse bone morphogenetic protein; plus, Beckman Coulter agrees to pony up $5.5M to settle shareholders' class-action lawsuit.
Personal injury lawsuits over its controversial Infuse bone-growth protein are beginning to pile up for Medtronic Inc. (NYSE:MDT), after the Spine Journal revealed serious concerns about the device's safety this summer.
The FDA warns Beckman Coulter on multiple quality issues at its California manufacturing plant, including issues related to its Class 1 recall of an electrolyte assay in May.
The FDA filed a Warning Letter against Beckman Coulter Inc. (NYSE:BEC) this month, detailing a long list of alleged quality issues surrounding the company's manufacturing facility.
Based on an investigation of Beckman's Brea, Calif.-based facility, the watchdog agency found problems with design validation processes, design change processing procedures, personnel training and reporting and execution systems for corrective and preventative actions, among other complaints.
The FDA announces a Class I recall for Beckman Coulter's Synchron clinical chemistry analyzers.
The FDA put a Class I recall on Beckman Coulter Inc.'s (NYSE:BEC) Synchron clinical chemistry analyzer.
The device is a computer-controlled clinical analyzer for determining chemistries in various fluids including blood, urine and cerebrospinal fluid.
Duke University creates $20 million endowment for biomedical engineering research with an eye on clinician collaboration and commercialization.
Duke University has established a new $20 million biomedical endowment to support a program that has had a knack for launching new medical companies, focusing in particular on medical technology.
The new endowment will allow the program to continue at Duke in perpetuity.
Duke was one of nine universities chosen by the Coulter Foundation in 2005 to accelerate technology transfer of university biomedical engineering projects into commercial products and clinical practices.
Siemens adds to its $45 million win over Saint-Gobain; a Beckman Coulter investor sues to block Danaher deal; and Mass. General Hospital agrees to pony up $1 million after a worker leaves patients' medical records on a subway train.
Siemens survives in Saint-Gobain suit
Siemens AG (ETR:SIE) survived a bid to toss a $44.9 million patent infringement verdict by Saint-Gobain SA (EPA:SGO), according to Bloomberg.